Several studies have demonstrated that NAFLD is associated with insulin resistance leading to a resistance in the antilipolytic effect of insulin in the adipose tissue with an increase of free fatty acids (FFAs). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.